Page URL: https://www.bionews.org.uk/page_90394

Embryo tests carry no extra health risk

19 June 2007
Appeared in BioNews 412

Carrying out genetic tests on embryos has no effect on the health of the resulting babies, according to new findings reported at the annual meeting of the European Society of Human Genetics. The researchers, based at Brussels' Free University, followed up over 500 babies born following the use of PGDThey compared the children with those conceived using either standard IVF, or ICSI during which a single sperm is injected directly into an egg.

PGD involves removing a single cell from a 3-5 day old embryo created using IVF or ICSI, to check for the presence of gene mutation or chromosome abnormality responsible for a medical condition. Since all the cells that make up the embryo at this stage are 'totipotent' - able to develop into any body tissue - removing a single cell is believed to have no effect. Unaffected embryos, if any are identified, can then be transferred to the mother's womb to continue developing.

PGD has been used by couples who are at high risk of passing on serious genetic disorders to their children since the early 1990s. Since then, there have been calls to track children born after PGD to monitor their long-term health. In the latest study, the scientists studied 583 pregnancies, which resulted in 563 live births. Twenty were stillborn, and nine died shortly after birth. The team assessed the health of the children at the age of two months, and again at two years.

The researchers found that at 3.6 per cent, the rate of major birth defects in the PGD babies was no higher than that in the IVF or ICSI groups. However, team leader Professor Ingeborg Liebaers said that the perinatal death rate needed further investigation, as it was higher in the PGD group - particularly following multiple pregnancies. But overall she said the results were 'reassuring', adding 'it is good to know that a procedure that can offer patients hope of having a baby unaffected by serious disease is also safe in the longer term'.

Commenting on the findings, PGD pioneer and British Fertility spokesman Professor Alan Handyside said that he was 'very reassured and not at all surprised by these latest results'. However, he told BBC News Online that it would take several more decades to look at the longer term outcomes - the oldest PGD children are now 17. He said that the higher perinatal death rate was unexpected and should be investigated, as it could be a statistical anomaly.

SOURCES & REFERENCES
Gene screening 'safe' for babies
BBC News Online |  17 June 2007
Health of babies not affected by embryo screening
News-Medical.net |  18 June 2007
Preimplantation Genetic Diagnosis Okay For Test-tube Babies, Study Finds
ScienceDaily |  18 June 2007
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
29 April 2005 - by BioNews 
All centres carrying out preimplantation genetic diagnosis (PGD) should be following up the resulting babies to track any long term effects on their health, a UK doctor has said. Peter Braude, of Kings College London, one of eight UK centres offering the treatment, called for more long-term studies at a...
20 August 2004 - by BioNews 
Carrying out genetic tests on embryos appears to have no effect on the health of the resulting children, according to a new US study. Scientists at three institutes pooled their data on all PGD babies born during the past 12 years, a total of 754. The research, reported in the...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.